EOSCAPE™ Molecular Diagnostics Technology
EOSCAPE is a revolutionary molecular diagnostics system that, for the first time, brings sophisticated, high-clinical-value molecular testing directly into the smaller hospitals and clinics which provide the vast majority of patient care in healthcare systems around the world. Key aspects of EOSCAPE technology include:
Enclosed cartridges with fully integrated sample preparation.All assay processes, including DNA/RNA extraction and other sample preparation steps, take place within fully enclosed EOSCAPE cartridges. All reagents are contained on-board the cartridge at all times.
Fast turnaround times.From sample-in to results-out in 10-55 minutes, depending on type of target.
Diverse panels of high-clinical-value analytes.Beyond the EOSCAPE-HIV for HIV viral load measurement, the EOSCAPE pipeline includes hepatitis B DNA, chlamydia DNA, and many other established and emerging biomarkers—both nucleic acids and proteins.
Accurate, sensitive quantitation of target analytes.EOSCAPE lower limits of detection are as low as a few copies of target per sample; quantitation spans some six logs of dynamic range.
Versatile configurations and high reliability.An innovative instrumentation configuration—with primary assay processes taking place in small processing units, which are inserted into the main analyzer for final read-out—enables fully on-demand testing in clinics with test throughputs ranging from a few tests per day to more than fifty. Routine maintenance requirements are almost zero.
Highly competitive on a cost-per-result basis.Typical EOSCAPE cartridge costs are 25-60% below comparable testing systems.